Evidence of pseudoprogression in patients treated with PD1/PDL1 antibodies across tumor types

BACKGROUND: PD(L)1 antibodies (anti‐PD(L)‐1) have been a major breakthrough in several types of cancer. Novel patterns of response and progression have been described with anti‐PD(L)‐1. We aimed at characterizing pseudoprogression (PSPD) among patients with various solid tumor types treated by anti‐...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Martin‐Romano, Patricia, Castanon, Eduardo, Ammari, Samy, Champiat, Stéphane, Hollebecque, Antoine, Postel‐Vinay, Sophie, Baldini, Capucine, Varga, Andrea, Michot, Jean Marie, Vuagnat, Perrine, Marabelle, Aurélien, Soria, Jean‐Charles, Ferté, Charles, Massard, Christophe
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Clinical Cancer Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7163099/
https://ncbi.nlm.nih.gov/pubmed/32074405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2797
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados